Unregister. Tiklid®

July 26, 2017
Active substances:
Trade names:
ICD-10:
IX.I20-I25.I21    Acute myocardial infarction
IX.I26-I28.I26    Pulmonary embolism
IX.I60-I69.I63    Cerebral infarction
IX.I70-I79.I74    Embolism and thrombosis of the arteries
IX.I80-I89.I82    Embolism and thrombosis of other veins
Tiklid, ticlopidine, thrombosis prophylaxis, pulmonary embolism

The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclude from the state register of medicinal products for medical useof the medicinal product (registration certificate P N013007 / 01 dated 09.04.2008 issued by Sanofi-Aventis France, France):

Tiklid® (trade name of the medicinal product)

Ticlopidine (international non-proprietary or chemical name of the drug)

film coated tablets, 250 mg (dosage form, dosage)

Sanofi-aventis SAU, Spain Ctra. De la Batlloria a Hostalric, Km 1,4-17404 Riells i Viabrea, Spain (name and address of the location of the manufacturer of the medicinal product)

on the basis of an application by the authorized legal entity of the Sanofi-aventis Group JSC (France), Russia, to cancel the state registration of the medicinal product.